News and Events from TessArae, LLC
BioArray News: TessArae, GeneDx Develop Array-Based Tests for Noonan, Periodic Fever Syndromes
Looking to move into the genetic-disease testing market, TessArae this week announced a deal with GeneDx to develop and launch array-based tools for detecting the genetic mutations responsible for several diseases.
Under the terms of the deal, Potomac Falls, Va.-based TessArae will provide Gaithersburg, Md.-based GeneDx with arrays and software to detect all known mutations in eight genes of the RAS/MAPK pathway that are associated with Noonan Syndrome, a genetic disorder that causes abnormal development of multiple parts of the body.
The two firms are also developing a test for Periodic Fever Syndromes that GeneDx said it will commercialize in coming weeks. According to the Cleveland Clinic, Periodic Fever Syndromes are diseases that cause episodic fevers in patients and do not have an infectious cause.
Tags: genetic testing